Back to search
FDAFDA · Food and drugs·Recall number D-0478-2020

Altaire Ciprofloxacin HCl Ophthalmic Solution, 0.3%, 5 mL, NDC 59390-217-05

Published November 27, 2019 · Recall initiated: July 2, 2019

Summary

FDA records drug Class II recall D-0478-2020, published November 27, 2019 and initiated July 2, 2019. Recalling firm: Altaire Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 6024 units; Lot: Lot #: 18164, Exp 7/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if CIPROFLOXACIN HCL OPHTHALMIC has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CIPROFLOXACIN HCL OPHTHALMIC
Manufacturer
Altaire Pharmaceuticals, Inc.
Distributor
U.S.A. Nationwide
UPC
4776638217054
Lot
Lot #: 18164, Exp 7/20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Altaire Ciprofloxacin HCl Ophthalmic Solution, 0.3%, 5 mL, NDC 59390-217-05 recalled?

Yes. FDA published recall D-0478-2020 on November 27, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CIPROFLOXACIN HCL OPHTHALMIC. UPC: 4776638217054.